跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 2,353 条关于
“PULSAR”
全部
2,353
临床试验
2,186
药物
64
机构
19
资讯
84
去年
High-Dose Aflibercept Shows Superior Fluid Control in 96-Week PULSAR Trial Analysis for Wet AMD
去年
Vabysmo Shows Superior CST Reduction Compared to Eylea HD in DME and nAMD: Meta-Analysis
2年前
Bayer's High-Dose Eylea 8mg (Aflibercept) Accepted for Review by China's NMPA Following UK Approval
2年前
EMA Approves Pre-filled Syringe for Eylea 8 mg, Enhancing AMD and DME Treatment
去年
Novel Contact Force-Sensing Pulsed Field Ablation Catheter Shows Promise in Paroxysmal AF Treatment
去年
UT Southwestern Breaks Ground on $177M Radiation Oncology Campus in Fort Worth
去年
Aflibercept 8 mg Shows Extended Dosing Intervals in Real-World nAMD Treatment
去年
ATS 2025 Conference to Showcase Groundbreaking Pulmonary Research and Patient-Centered Initiatives
上个月
Pulse Biosciences Surpasses Enrollment Midpoint in NANOPULSE-AF Pivotal Trial for Nanosecond Pulsed Field Ablation
9个月前
Pulse Biosciences Advances Nanosecond Pulsed Field Ablation Technology with FDA Approvals for Cardiac and Thyroid Cancer Studies
第 1 页,共 9 页
上一页
下一页